CLUSTER filed Aug 5, 2026 at 16:05 ET
Five Twist Bioscience insiders, including CEO Emily Leproust and President/COO Patrick Finn, sold a combined $884K in open-market shares on August 3, 2026, the same day the company reported a strong fiscal Q3 2026 beat-and-raise earnings. The cluster is entirely composed of sales, totaling ~0.01% of the $7.2B market cap, which is below the 0.1% materiality threshold and thus routine. The sales are likely driven by the post-earnings blackout window opening and pre-planned 10b5-1 programs, not a bearish signal on fundamentals.